An interventional study of Best practice algorithm for postoperative care in Pancreatic Diseases, Pancreatic Neoplasms and Pancreatic Cancer, sponsored by St. Antonius Hospital. Status unknown at 17 sites in Netherlands. Per ClinicalTrials.gov, last updated 2019-06-14.
Sponsored by St. Antonius Hospital · Not applicable, Interventional, and Treatment
This Nationwide stepped-wedge cluster randomized trial is designed to evaluate if the implementation of a best practice algorithm for postoperative care results in a decrease in incidence of major complications and death after pancreatic resection as compared to current practice.
Rationale
Pancreatic resection is a major abdominal operation with 50% chance of postoperative complications. A feared complication is severe pancreatic fistula, in which there is leakage of enzyme rich fluid into the abdominal cavity. Adequate complication management appears to be the most important factor in improving outcomes of patients undergoing pancreatic resection.
Objective
To investigate whether implementation of a best practice algorithm for postoperative care focusing on early detection and step-up management of postoperative pancreatic fistula results in a lower rate of major complications and death after pancreatic resection as compared to current practice
Study design
A nationwide stepped-wedge, cluster randomized, superiority trial. In this design all participating centers cross over from current practice to best practice according to the algorithm, but are randomized to determine the exact order. At the end of the trial, all centers will have implemented the best practice algorithm.
Study population
All centers performing pancreatic surgery in the Netherlands (i.e. the Dutch Pancreatic Cancer Group).
Intervention
Cluster level education on postoperative care according to a best practice algorithm, focusing on early detection and step-up management of postoperative pancreatic fistula. This algorithm is based on findings in Dutch observational cohort studies, systematic literature analyses, an inventory in current protocols on postoperative care and expert opinion. The proposed algorithm is validated in a multicenter cohort and consensus upon this algorithm is reached with pancreatic surgeons from all centers of the Dutch Pancreatic Cancer Group. The final algorithm was reviewed critically by the advisory committee of internationally respected experts in the field of pancreatology before implementation in this trial.
Comparison
Postoperative care according to current practice.
Endpoints
The primary outcome was measured in all patients undergoing pancreatic resection and is a composite of major complications (i.e. postpancreatectomy bleeding, new-onset organ failure and death). Secondary endpoints include the individual components of the primary endpoint and other clinical outcomes, number of patients receiving adjuvant chemotherapy, healthcare resource utilization and costs analysis. Follow-up will be 90 days after pancreatic resection.
Inclusion Criteria for Clusters:
Exclusion Criteria for Clusters:
Inclusion Criteria for Patients:
Exclusion Criteria for Patients:
Postoperative care according to a best practice algorithm for postoperative care focussing on early detection and minimally invasive management of postoperative pancreatic fistula.
Other: Best practice algorithm for postoperative care
Postoperative care according to current usual practice.
See arm/group description
Composite primary endpoint
The primary endpoint of this trial is a composite of the most severe complications associated to postoperative pancreatic fistula. This endpoint will be considered positive if one of the following complications occurs within 90 days after pancreatic resection: late postpancreatectomy bleeding, new-onset organ failure and/or death
Time frame: 90 days after index pancreatic resection
Postoperative mortality
Measured as rate of death at 90-day follow-up
Time frame: 90 days after index pancreatic resection
New-onset organ failure
Measured as organ failure occuring any time within 90 days after resection, not present at time of index pancreatic resection.
Time frame: 90 days after index pancreatic resection
Late postpancreatectomy bleeding
Defined in accordance to the International Study Group on Pancreatic Surgery (ISGPS) definition as bleeding occurring any time after 24 hours after pancreatic resection.
Time frame: 90 days after index pancreatic resection
Postoperative morbidity
Including complications according to the Clavien-Dindo system and pancreatectomy specific complications according to the ISGPS definitions (e.g. postpancreatectomy bleeding, postoperative pancreatic fistula, postoperative bile leak, postoperative chyle leak and delayed gastric emptying).
Time frame: 90 days after index pancreatic resection
Adjuvant chemotherapy
Measured as number of patients receiving adjuvant chemotherapy at 90-day follow-up
Time frame: 90 days after index pancreatic resection
Success of implementation
Measured as number of patients in whom the algorithm was not followed and timing of abdominal CT scans in both strategies.
Time frame: 90 days after index pancreatic resection
Cost-effectiveness
Calculated by comparing health effects and medical costs related to both strategies up to 90 days after pancreatic resection.
Time frame: 90 days after index pancreatic resection
Plan to share: Yes — The datasets generated during and/or analysed during the current study are/will be available upon request from Hjalmar van Santvoort (h.van.santvoort@antoniusziekenhuis.nl)
Supporting information: Study protocol
This study is status unknown, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
St. Antonius Hospital